Journal Article
Differential DNA methylation and CTCF binding between the ESR1 promoter a of MCF-7 and MDA-MB-231 breast cancer cells
Edén Víctor Montes-de-Oca-Fuentes; Karina Jácome-López; Anaís Zarco-Mendoza; Georgina Guerrero; José Luis Ventura-Gallegos; Sergio Juárez-Méndez; Alberto Jose Cabrera-Quintero; Félix Recillas-Targa; Alejandro Zentella-Dehesa
Molecular Biology Reports · Vol. 51, Issue 1 · 2024
Abstract
Background ESR1 is expressed by 60–70% of breast tumours. it’s a good prognosis factor and the target of hormone therapy. Optimization of ESR1 reactivation therapy is currently ongoing. Here we probe if the transcription factor CTCF plays a role in the differential expression of ESR1 in the breast cancer cell lines MCF-7 (ESR1+) and MDA-MB-231 (ESR1-). Methods and results Knockdown of CTCF in MCF-7 resulted in decreased ESR1 gene expression. CTCF binds to the promoter of ESR1 in MCF-7 but not in MDA-MB-231 cells. CTCF ESR1 binding sites are unmethylated in MCF7 but methylated in MDA-MB-231 cells. Conclusion ESR1 expression in MCF7 cells is dependent on CTCF expression. CTCF can bind to specific regions of the promotor of ESR1 gene in MCF-7 cells but not in MDA-MB-231 cells, this correlates with the methylation status of these regions and could be involved in the transcriptional regulation of ESR1.
Bibliographic Information
| Journal | Molecular Biology Reports |
|---|
| Publisher | Springer |
|---|
| Publication Date | 2024-12-01 |
|---|
| Publication Year | 2024 |
|---|
| Volume | 51 |
|---|
| Issue | 1 |
|---|
| Document Type | Journal Article |
|---|
| Print ISSN | 0301-4851 |
|---|
| eISSN | 1573-4978 |
|---|
| DOI | 10.1007/s11033-023-09171-0 |
|---|
Access Information
Full-text access depends on NARA's subscribed coverage and institutional access.